Similarly, in solid tumors such as breast cancer and thyroid cancer, CCL3 binding to CCR5 upregulates MMPs and activates the NF-κB pathway, thereby enhancing cancer cell invasiveness and migration [31, 32]. This evidence concerns the gene CCR5 and thyroid gland carcinoma.